Oxford COVID-19 vaccine: newly published results show it is safe – but questions remain over its efficacy →

Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca – has been published in the Lancet. This paper represents the most comprehensive set of results from any of the phase 3 trials of COVID-19 vaccines to date. THE CONVERSATION